universita' degli studi di milano - Alessandro Guerini Rocco

63. Ignar-Trowbridge, D.M., M. Pimentel, M.G. Parker, J.A. McLachlan, and K.S.
Korach, Peptide growth factor cross-talk with the estrogen receptor requires
the A/B domain and occurs independently of proteine kinase C or estradiol.
Endocrinology, 1996. 137: p. 1735-44.
64. Ciana, P., S. Ghisletti, P. Mussi, I. Eberini, E. Vegeto, and A. Maggi, Estrogen
receptor alpha, a molecular switch converting transforming growth factor-alpha-mediated
proliferation into differentiation in neuroblastoma cells. J Biol
Chem, 2003. 278(34): p. 31737-44.
65. Campbell, R.A., P. Bhat-Nakshatri, N.M. Patel, D. Costantinidou, S. Ali, and
H. Nakshatri, Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen
receptor α. J Biol Chem, 2001. 276: p. 9817-24.
66. Zwijsen, R.M., E. Wientjens, R. Klompmaker, J. van der Sman, R. Bernards,
and R.J. Michalides, CDK-indipendent activation of estrogen receptor by ciclin
D. Cell, 1997. 88: p. 405-15.
67. Rogatsky, I., J.M. Trowbridge, and M.J. Garabedian, Potentation of human
estrogen receptor α transcriptional activation through phosphorylation of serines
104 and 106 by cyclin A-CDK2 complex. J Biol Chem, 1999. 274: p.
22296-302.
68. El Tanani, M.K. and C.D. Green, Two separate mechanisme for ligand-indipendent
activation of the estrogen receptor. Mol Endocrinol, 1997. 11: p. 928-
37.
69. Coleman, K.M., M. Dutertre, A. El-Gharbawy, B.G. Rowan, N.L. Weigel, and
C.L. Smith, Mechanistic differences in activation of estrogen receptor-α (ER
α) and ERß-dipendent gene expression by AMP signaling pathway(s). J Biol
Chem, 2003.
70. Tremblay, G.B., A. Tremblay, F. Labrie, and V. Giguere, Ligand-indipendent
activation of the estrogen receptors α and ß by mutation of a conserved tyrosine
can be abolished by antiestrogens. Cancer res, 1998. 58: p. 877-81.
71. Kurebayashi, S., Y. Miyashita, T. Hirose, S. Kasayama, S. Akira, and T. Kishimoto,
Characterization of mechanisms of interleukin-6 gene repression by
estrogen receptor. J Steroid Biochem Mol Biol, 1997. 60(1-2): p. 11-7.
72. Galien, R., H.F. Evans, and T. Garcia, Involvement of CCAAT/enhancer-binding
protein and nuclear factor-kappa B binding sites in interleukin-6 promoter
inhibition by estrogens. Mol Endocrinol, 1996. 10(6): p. 713-22.
73. Galien, R. and T. Garcia, Estrogen receptor impairs interleukin-6 expression
by preventing protein binding on the NF-κB site. Nucleic Acids Research,
1997. 25(12).
74. Deshpande, R., H. Khalili, R.G. Pergolizzi, S.D. Michael, and M.D. Chang,
Estradiol down-regulates LPS-induced cytokine production and NFkB activation
in murine macrophages. Am J Reprod Immunol, 1997. 38(1): p. 46-54.
75. Ray, P., S.K. Ghosh, D.H. Zhang, and A. Ray, Repression of interleukin-6
gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of
the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor.
FEBS Lett, 1997. 409(1): p. 79-85.
76. Ray, A., K.E. Prefontaine, and P. Ray, Down-modulation of interleukin-6 gene
expression by 17 beta-estradiol in the absence of high affinity DNA binding by
the estrogen receptor. J Biol Chem, 1994. 269(17): p. 12940-6.
127